Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-23

Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating DFD-04 for rosacea has completed and results were posted in January 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DFD-04

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23